Workflow
Couloir Capital is Pleased to Announce That it Has Updated its Research Coverage on North Peak Resources
TMX Newsfile· 2026-02-27 13:15
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Couloir Capital is pleased to announce that it has updated its research coverage on North Peak Resources Ltd. (TSXV: NPR) (OTCQB: NPRLF) (or "Company"). Couloir Capital's Senior Mining analyst, Ron Wortel, MBA, P.Eng., QP, crafted a report titled "Drilling targeting resource development and regional consolidation, driving interest in this Nevada explorer." Report excerpt: "We are updating our coverage of North Peak Resources as it is syste ...
Celsius Q4: Strong Results, Significant Upside
Seeking Alpha· 2026-02-27 13:15
Group 1 - The REIT Forum offers exclusive investment ideas and access to subscriber-only portfolios [1] - Amrita leads a boutique family office fund in Vancouver, focusing on sustainable, growth-driven companies [2] - The fund aims to maximize shareholder equity by meeting growth-oriented goals [2] Group 2 - Amrita has experience in high-growth supply-chain start-ups and has worked with venture capital firms [2] - Her newsletter, The Pragmatic Optimist, focuses on portfolio strategy, valuation, and macroeconomics [2] - The newsletter has been recognized as a top finance newsletter and aims to democratize financial literacy [2]
Jack Dorsey sounds layoff alarm after Block slashes 50% staff — which companies could be next?
The Economic Times· 2026-02-27 13:14
: For thousands of white-collar workers, the future suddenly feels less certain. Jack Dorsey announced that Block, the parent company of Square and Cash App, will cut nearly half of its workforce, reducing its headcount from more than 10,000 employees to just under 6,000. That means more than 4,000 people are losing their jobs, even as Dorsey says the business itself is strong and profits are growing.Why is Block Cuting Over 4,000 Jobs At Once Instead of Multiple Rounds of LayoffsIn a post on X, Dorsey exp ...
COPEL - Copel Recorded Recurring Ebitda of R$ 1,358.1 Million in 4Q25, an Increase of 16.1% Compared to R$ 1,169.6 Million Recorded in 4Q24
TMX Newsfile· 2026-02-27 13:14
Core Insights - Copel reported a recurring Ebitda of R$ 1,358.1 million in 4Q25, marking a 16.1% increase from R$ 1,169.6 million in 4Q24, demonstrating the company's strong asset base and effective operational strategy [1] Group 1: Financial Performance - Genco's Ebitda increased by 24.3% (+R$ 127.8 million) to R$ 654.2 million in 4Q25, driven by higher revenue from electricity grid availability, reduced manageable costs, and positive effects from short-term market transactions [2] - Elejor's Ebitda rose by R$ 23.6 million compared to 4Q24, attributed to increased energy trading volumes in bilateral contracts and higher average sale prices [3] - TradeCo's Ebitda grew by R$ 18.8 million compared to 4Q24, primarily due to a 69.7% increase in energy sales in bilateral contracts, totaling 3,824 GWh [3] Group 2: Cost and Pricing Factors - The increase in Genco's Ebitda was partially offset by higher costs of electricity purchased for resale, with GSF decreasing to 67.4% in 4Q25 from 79.9% in 4Q24, and PLD rising to R$ 264.70/MWh from R$ 216.36/MWh [3] - DisCo's Ebitda saw a 1.8% increase (+R$ 13.1 million) compared to 4Q24, mainly due to the Annual Tariff Adjustment (RTA) in June 2025, which had an average effect of 1.3% on portion B [3]
INVESTOR NOTICE: CoreWeave, Inc. (CRWV) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law
Globenewswire· 2026-02-27 13:14
SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CoreWeave, Inc. (NASDAQ: CRWV) securities between March 28, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), have until Friday, March 13, 2026 to seek appointment as lead plaintiff of the CoreWeave class action lawsuit. Captioned Masaitis v. CoreWeave, Inc., No. 26-cv-00355 (D.N.J.), the CoreWeave class action lawsuit charges CoreWeave as well as certain of CoreWeave’ ...
Strength Seen in SailPoint, Inc. (SAIL): Can Its 7.5% Jump Turn into More Strength?
ZACKS· 2026-02-27 13:13
Core Insights - SailPoint, Inc. (SAIL) shares increased by 7.5% to $14.37 in the last trading session, following a significant volume of trading, contrasting with a 22.7% decline over the past four weeks [1] Company Performance - SailPoint, Inc. is expected to report quarterly earnings of $0.08 per share, reflecting a year-over-year increase of 101.9%. Revenue is projected to reach $292.53 million, which is a 21.8% increase from the same quarter last year [3] - The consensus EPS estimate for SailPoint has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] Industry Context - SailPoint, Inc. is integrated with Amazon Web Services (AWS) through a new extended plan in AWS Security Hub, allowing customers to manage identity security and governance more efficiently [2] - SailPoint operates within the Zacks Internet - Software industry, where another company, Exodus Movement, Inc. (EXOD), has seen a 1.7% decline in its stock price, with a 25.8% drop over the past month [4]
5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years
247Wallst· 2026-02-27 13:11
Core Insights - The article highlights five US blue-chip companies that have consistently paid dividends for over 100 years, indicating their financial durability and strong management practices [1][2]. Company Summaries - **Coca-Cola (NYSE: KO)**: Founded in 1892, Coca-Cola has paid dividends since 1893, currently yielding 2.58%. It is the world's largest beverage company with over 500 brands and serves more than 1.9 billion servings daily across 200 countries. Morgan Stanley rates it Overweight with a target price of $87 [1][2]. - **Colgate-Palmolive (NYSE: CL)**: This consumer staples giant has paid dividends since 1895, yielding 2.14%. The company focuses on Oral Care, Personal Care, Home Care, and Pet Nutrition, selling products under various well-known brands. Goldman Sachs has a Buy rating with a target price of $100 [1][2]. - **Eli Lilly (NYSE: LLY)**: A healthcare company that has paid dividends since 1885, currently yielding 0.59%. Eli Lilly develops and markets pharmaceutical products, including those for cardiometabolic health and oncology. Barclays rates it Overweight with a target price of $1,350 [2]. - **Exxon Mobil (NYSE: XOM)**: This integrated oil and gas company has paid dividends since 1882, with a current yield of 2.67%. Exxon is a leader in crude oil and natural gas production and has a strong capital allocation strategy. UBS has a Buy rating with a target price of $171 [2]. - **Stanley Black & Decker (NYSE: SWK)**: The largest tool company globally, it has paid dividends for over 145 years, currently yielding 3.68%. The company offers a wide range of tools and accessories and is expected to benefit from a potential economic slowdown. Citigroup has a Buy rating with a target price of $100 [2].
Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
Prnewswire· 2026-02-27 13:11
Core Viewpoint - Eli Lilly's Olumiant (baricitinib) has received a positive opinion from the European Medicines Agency's CHMP for expanded use in adolescents aged 12 to under 18 with severe alopecia areata, based on promising data from the Phase 3 BRAVE-AA-PEDS study [1][2]. Group 1: Clinical Study Results - The Phase 3 BRAVE-AA-PEDS study showed that 42.4% of adolescents treated with Olumiant achieved 80% or more scalp hair coverage at 36 weeks, compared to 4.5% in the placebo group [1]. - Near-complete scalp hair coverage (90%) was achieved by 36.5% of patients on Olumiant, while only 2.3% of those on placebo reached this level [1]. - Significant eyebrow regrowth was observed in 50% of patients on Olumiant, compared to 0% in the placebo group [1]. - Eyelash regrowth was reported in 42.9% of patients treated with Olumiant, versus 14.0% in the placebo group [1]. Group 2: Regulatory and Market Implications - The positive CHMP opinion is a step towards European regulatory approval, with a decision from the European Commission expected in the next one to two months [1]. - Lilly has also submitted Olumiant for approval in the U.S. for treating severe alopecia areata in adolescents, with a decision anticipated in the second half of 2026 [1][2]. - Olumiant is already approved for adult patients with severe alopecia areata in the U.S. and Europe, marking it as the first JAK inhibitor approved for this indication [1][2]. Group 3: Safety and Efficacy Profile - The safety profile of Olumiant in adolescents aligns with previous clinical trials for other conditions, such as juvenile idiopathic arthritis and atopic dermatitis [1]. - Over 14,600 patients have participated in clinical trials involving Olumiant, with more than 1,200 being children and adolescents [1]. - The ongoing BRAVE-AA-PEDS trial includes a cohort of children aged 6 to under 12 years, further expanding the understanding of Olumiant's safety and efficacy in younger populations [1].
One Big Reason Nvidia's Stock Is Stuck In The Mud: Lack Of Direct Shareholder Rewards
Seeking Alpha· 2026-02-27 13:10
分组1 - NVIDIA reported a strong quarterly performance, exceeding both revenue and earnings expectations, and provided guidance that surpassed analyst estimates for the next quarter [1] - The market reaction to NVIDIA's report was unexpected, with a sell-off occurring despite the positive results [1] 分组2 - Michael Fitzsimmons, a retired electronics engineer, suggests that investors should build a diversified portfolio with a focus on a high-quality low-cost S&P 500 fund [1] - For those willing to accept short-term risks, an overweight position in the technology sector is recommended, as it is believed to be in the early stages of a long-term bull market [1] - Fitzsimmons also advises considering investments in large oil and gas companies for strong dividend income and growth [1] - His portfolio management approach emphasizes a top-down capital allocation strategy tailored to individual investor circumstances, including age, risk tolerance, and financial goals [1]
Gold price slightly up, silver higher ahead of U.S. PPI
KITCO· 2026-02-27 13:09
Group 1 - Jim Wyckoff has over 25 years of experience in stock, financial, and commodity markets, including roles as a financial journalist and reporter on commodity futures trading floors in Chicago and New York [1] - He has covered every futures market traded in the U.S. at various times throughout his career [1] - Jim is the owner of "Jim Wyckoff on the Markets," which provides analytical, educational, and trading advisory services [2] Group 2 - He has worked as a technical analyst for Dow Jones Newswires and as a senior market analyst with TraderPlanet.com [2] - Jim is also a consultant for the "Pro Farmer" agricultural advisory service and was the head equities analyst at CapitalistEdge.com [2] - He holds a degree in journalism and economics from Iowa State University [2]